Caldolor Versus Caldolor Plus OFIRMEV in Total Knee or Hip Arthroplasty Surgeries

Completed · Phase 4

Conditions studied: Pain

In brief

The objective of this study is to compare the effectiveness and of perioperative use of Caldolor alone and in combination with OFIRMEV in total knee or hip arthroplasty procedures.

Key facts

Study ID

NCT01773005

Run by

Anita Gupta

People needed

78

Starts

2012-12-01

Expected to finish

2014-12-01

Last updated by the study team

2016-02-29

Who can join

Age: 18 and older, up to 70. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Adult patients age 18-70 scheduled for total knee or hip arthroplasty surgery
• American Society of Anesthesiology physical status I, II, III

You may not qualify if…

• Impaired liver function
• History of substance abuse or chronic pain
• Patients known to be hypersensitive to any of the components of Caldolor or Ofirmev
• Patients less than 18 years of age.
• Inability to understand the requirements of the study or be unwilling to provide written informed consent (as evidenced by signature on an informed consent document approved by an Institutional Review Board [IRB]) and agree to abide by the study restrictions.
• Be pregnant or nursing
• Be otherwise unsuitable for the study, in the opinion of the Investigator.

Where it is running

• University Pain Institute Hahnemann Hospital — Philadelphia, Pennsylvania, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.